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Abstract Communication of risk profiles associated
with sunscreens incorporating nanoparticles has been
challenging when some communicators shift risk
profiles from highly problematic nanoparticles to
others, which are much less problematic. This article
vets a popular publication from a civic advocacy
group that cited scientific research papers to make
environmental health and safety claims. The phe-
nomenon of risk profile shifts is demonstrated by
re-examining the scientific articles being cited. In
addition, the authors for correspondence for each of
the articles cited were interviewed via email and their
comments about the claims made are included.
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Introduction
The public debates over the health and safety of
nanoparticles are a mess and blame rests nearly
everywhere. The confusion started with rhetorical
flourishes describing nanoscience as revolutionary
and nanotechnology as the next industrial revolution.
Nearly simultaneously and in part responding to
warnings from environmentalists, we had claims that
nanoscience was not particularly dangerous because it
was simply evolutionary, the next step in chemistry
and material sciences. Next we had a series of
metaphors applied to nanotechnology. The public
was entertained with broad estimations of nanoscience
and nanotechnologies as analogous to genetically
modified organisms (GMOs), especially as they
pertained to foodstuffs marketed in Western Europe
by American-based transnational corporations. Link-
ing nanotechnology to GMOs rhetors intended to
transfer the negative valence associated with the GMO
fiasco to the bourgeoning field of nanoscience. This
was followed closely with claims that should a
business or group market products, which may have
a high negative risk profile; then the entire industry
would collapse under the weight of negative publicity.
This phenomenon is a little more sophisticated than
transference has been called contagion, sometimes the
cascade or bandwagon effect, and is a much denser
than a simple correlation. The next major rhetorical
jab came in the form of testimony from environmental
health and safety (EHS) researchers who argued that
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nanoparticles functioned differently than particles
larger in size and as such their risk profiles may be
unique making standard setting especially problem-
atic. Environmental activists and some civil advocacy
groups (CAG) grabbed onto this concept and began to
ask whether regulators were positioned to protect
public safety. Toxicologists crooned that there was
insufficient information and much more research on
EHS was needed. In response, some environmentalists
and CAGs demanded pre-emptive precautionary
measures including moratoria. Finally, we need to at
least tip our hats to the role media has played in
attenuating and amplifying the EHS profiles of some
nanoproducts. The media love to portray issues as
disaster events, including EHS reports about emerging
technologies.
Cumulatively, this level of discord has frustrated
the public’s capacity to wring something intelligible
out of the EHS debate. After examining report after
report in the nanosphere while at the University of
South Carolina’s NanoCenter, my NanoScience and
Technology Studies students and I noticed the
employment of a rhetorical device we dubbed risk
profile shifts. They seem to be employed primarily to
bias public opinion about the safety of some nano-
particles. In academia, authors could not get away
with such behavior. The review process is simply too
vigorous to allow questionable scholarship and
violators are punished in dozens of different ways.
However, nobody seems intent to police the nano-
sphere with equal vigilance.
Background
There are many fallacies in scientific debates, risk
profile shifting is one such and is derived from the
fallacies of division, equivocation, and hasty gener-
alization in symbolic logic and the term shift fallacy
in linguistics. The term shift fallacy occurs when a
term, which has different contextual meanings is
misleadingly used.
Why do you doubt the miracles described in the
Bible when you have witnessed miracles like man
(sic) landing on the moon? In the first occurrence,
miracle means something that defies the laws of
nature. In the second occurrence, miracle means
something amazing, that you would not have thought
could be done. The fact that the second kind of
miracle occurred does not make it more likely that the
first kind occurred. An argument that commits the
fallacy of equivocation would be valid if it were not
for the shift in meaning. When meaning shifts in
structurally significant ways, the pattern of the
argument is destroyed, and the conclusion does not
follow the premises. (Cedarbloom 1986).
The term shift fallacy can be intentional and
unintentional. Being obscure can be politically
advantageous (Vedung 1982). For example, journal-
ists understand that outrageous claims are potential
headliners and most editors want headline possibil-
ities within the text of any article. In a rhetorical
flourish, a journalist may misuse a term to purpose-
fully draw the attention to a claim being made.
At other times, the vocabulary is blameworthy: the
possible grouping of entities far exceeds the possible
words or terms in nearly everyone’s vocabulary.
Some languages simply have fewer words and terms
to express complex ideas: compare German or
Chinese to English. Some people simply have more
limited vocabularies than others.
According to Kaplan (1997), half the problems in
the world result from people using the same words
with different meanings. While this may be an
overclaim, it helps us to move to a phenomenon
found in many scientific arguments that has surfaced
in some EHS debates over nanoparticles.
Risk-profile shifts
Each event or phenomenon has a risk profile. The
profile is a composite of estimates of degree of
hazard, dosage variables drawn from studies, and
exposure variables often expressed as a probability.
Often, the event or phenomenon under examina-
tion belongs to a class or set of phenomena. If we
take the risk profile of one phenomenon in a class of
phenomena and transfer it to a different phenomenon
within the same class, the acceptability of the transfer
is clearly a function of how homogenous the class
from which the phenomenon was drawn may happen
to be. The more heterogeneous the class the higher
the likelihood of error and the transference in
question may be invalid.
Risk-profile shifting has become much too com-
mon in the EHS debates on nanoparticles. While it
would be first-class if this shifting was done with pure
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motivation, this may not be the case in this instance.
In too many situations, we have seen presumably
good people engaging in behavior, which is highly
questionable because of threats or perceived threats
to their self-esteem and well-being. This article calls
them to task.
Serious risk profile shifts surfaced over a year ago
after some effort was made to trace the sources found
in a report by a self-proclaimed non-governmental
organization, which called for a moratorium on all
nanoproducts. The project was frustrating for the
student researchers under my supervision because it
takes must less time to make an outrageous claim
than to rebut the same outrageous claim.
We discovered that when studies were reported the
rhetoric chosen to describe the findings was much
more totalistic or absolute than the researchers
admitted could be drawn from their own research.
Efforts on the parts of the researchers who actually
did the research to control how their findings would
be framed by others were simply ignored. For more
information on this experience, I refer to my blog
postings (http://www.nanohype.blogspot.com/).
The media attempt to prime public opinion by
overclaiming findings when they report tentative
findings as conclusive. While it might be excessive to
claim the media write the public agenda on EHS, it is
not an exaggeration to claim that the media and the
community of civil advocacy groups (hereafter
referred to as CAGs) together contribute significantly
to the public agenda. We expect more so than experts
in the field.
Unfortunately, both the media and the CAGs are
motivated to hyperbolize the findings on toxicity for
many of the same reasons: (1) the public reacts
positively to crisis rhetoric and prefers disaster to
objective and boring research findings; (2) the public
has been weaned on the rhetoric of fear for over a
decade and has grown comfortable to claims of
foreboding by parties of all sorts; (3) the public
assigns prestige value to sources of controversial and
unsetting information crediting them for uncovering
oftentimes conspiratorial findings; and (4) the public
responds with increased readership and membership
to those who break a newsworthy message about EHS.
Other stakeholders have different and sometimes
similar motives. Some media and CAGs are much
more concerned with presenting a balanced approach
to reports. Other media and CAGs stay out of debates
they are not prepared to engage. Some media and
CAGs subject what they publish to a higher level of
scrutiny than others. For example, there are many
CAGs, including but not limited to Environmental
Defense and Greenpeace, who have been valiant in
moderating their claims to avoid over dramatization.
Unfortunately, this restraint is not embraced by
everyone.
Talking about nanotechnology is challenging
enough. Not only is the subject highly technical for
public audiences, but also nanotechnology is incred-
ibly heterogeneous as a subject field. Broad
conclusions about nanotechnology and nanoparticles
are difficult to make and sustain.
• There is no single nanotechnology but many
nanotechnologies.
• Some industries may use a nanotechnology to
produce a finished product but that product may
not in itself contain nanoparticles.
• Nanoparticles can be functionalized in many
different ways and as such be differentiated from
another nanoparticle of the same sort but func-
tionalized in a different way.
• Nanoparticles can be freely mobile in the waste
stream or bound within a matrix, such as poly-
mers, though their status at the end of their life
cycle remains unknown.
• Nanoparticles aggregate during use and in some
instances their characteristics may be enhanced or
degraded with use and maybe through disposal as
well.
Most of the science world, the media, and CAGs are
correct when they claim that we do not know enough
about nanotechnology and nanoparticles to claim
they are safe. Oxygen and water are not safe when
taken in extremes: exposure and dosage matter. In
addition, nanoparticles must be compared to the
larger sized particles they may replace.
While the public is highly apprehensive about
uncertainty, there remains very little that the scien-
tific community can say about nanoparticles with any
certainty. Equivocation is the foundation of scientific
writing. The statements made by researchers on
questions of toxicity remain guarded. Finally, you
will be challenged to find any toxicologist to ever
admit there is enough information about toxic effects
to draw any conclusion whatsoever and this fuels
another level of discord. Some argue that uncertainty
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should be a ground for regulation if not total
prohibition (a moratorium), while the majority argue
that we need more research to determine the fate of
products using nanoparticles. No one seems to have
determined how much data is needed to fashion
reasonable regulations.
There is much to learn about the toxicology of
nanoparticles. The only conclusion to be drawn here
is that in some instances we might know enough to
make an intelligent assessment and in other instances
that is clearly not the case. Beyond the obvious:
exposure and dosage will affect the risk profile of
nanoparticles. Nanoparticles are very different from
particles of larger scale as they are from one another
and that discussion is ongoing. Carbon nanotubes are
different from nanosized titanium dioxide; some
forms (anatase, rutile, and brookite) of nanosized
titanium dioxide may be photoactive and other forms
are not; coated and nanosized titanium dioxide
produces different effects than its uncoated varieties
(they are coated with trimethyloctylsilane, Al2O3 or
SiO2, for example, to minimize reactivity while
maintaining UV diffraction). In addition, how nano-
particles are prepared for use in finished products can
produce effects due to the presence of trace materials
such as metals. Finally, the forms of the nanoparticles
shipped to companies making the final products can
produce different effects altogether.
However, using the risk profile from one of the
most likely toxic nanoparticle to characterize another
nanoparticle with a much more favorable risk profile
is simply misleading. To continue to do so when you
know better, is fear mongering and that is more than
misleading, it is wrong.
Sunscreens and risk profiles
During the summer of 2007, we assembled a team of
students to begin to tease out claims and counter-
claims in the nano-industry with the goal of publish-
ing brief guides for the general public. After years of
complaining about the absence of a public clearing-
house for EHS information on nanoparticles, it was
time to step forward. As long as these guides were
editable and organic in nature, we felt that they had
great potential to raise the quality of the debates on the
EHS of nanoparticles. As such, we started ‘‘Citizen
Guides on Nanotechnology’’ a joint project involving
the University of South Carolina and North Carolina
State University. At present, this project remains
unfunded by government, industry, and academe.
Nonetheless, our first guide will be on cosmetics
and sunscreens and our next two are on food (one on
production and the other on specific products and will
be available at our web sites). After reading almost
everything in print on the subject of cosmetics and
especially sunscreens, even we were able to deduce
that there were different classes of nanoparticles, such
as the nano-titanium oxide being used in sunscreens.
For example, we have noted a claim made by a
cosmetics company that when they buy titanium
oxides as nanopigments from companies, such as
BASF or Kobo, for incorporation into a sunscreen, they
purchase micronized aggregates (from 100 up to
600 nm in size) of these particles. The suppliers admit
the primary particles are typically between 0.2 and 0.3
lm in diameter, although larger aggregates and
agglomerates can be formed when coated with inor-
ganic (e.g., alumina, zirconia and silica) and organic
(e.g., polyols, esters, siloxanes and silanes) compounds
to control and improve surface properties (IARC
2006). This may increase the size of the aggregates.
Unfortunately, this report on the size of these aggre-
gates seems to be at odds with claims that ultrafine
grades of titanium dioxide (i.e., 10–50 nm) are used in
sunscreens and plastics to block ultraviolet light.
While this might be described as marketing rhetoric
describing ideal conditions, it might explain the
findings from Consumer Union on the ineffectiveness
of current sunscreens purportedly using nanoparticles.
We know that titanium oxide remains a reference
of non-toxicity which is why we find it used widely in
foodstuffs as a coloring agent (GSFA Online Food
Additive Details 2007) as well as some dental
products (WIPO 2002). It is generally insoluble,
inert, and coated. There are different types of
titanium oxide which are photoreactive nanoparticles
proposed to be used to help break down chemical
contamination in polluted areas by enhancing sun-
light’s effects. Of course, these are not the
nanopigments used in sunscreens.
The occurrence of skin cancer is growing all over
the planet with one American in five likely to develop
skin cancer in his lifetime. If the ozone layer continues
to decrease, the likelihood increases. And skin cancer
can kill you. Sunscreens were designed as one of the
many precautions individuals should take when they
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expose themselves to sunlight. Others include cover-
ings of all sorts, reducing exposure, and avoiding the
experience altogether. Companies produce sunscreens
with different SPFs from 2 to 60 and more (SPF stands
for sun protection factor and is calculated by
comparing the amount of time needed to produce a
sunburn on protected skin to the amount of time
needed to cause a sunburn on unprotected skin).
Companies add titanium dioxide and zinc oxide to
sunscreens because of their capacity to reflect and
scatter UV radiation. There are studies demonstrating
titanium dioxide reduces exposure to UV radiation
(Delrieu 2006; Nohynek and Schaefer 2001) as well
as studies linking extensive UV exposure to the
occurrence of skin cancer (Nohynek and Schaefer
2001; Pagoda and Preston-Martin 1996; Rooney and
Bryson 1991). The International Agency for Research
on Cancer has gone on record that nano-titanium
dioxide sunscreens are effective, the recent claims of
Consumer Reports (CR) notwithstanding (Consumer
Reports 2007).
In addition, companies use nano-titanium dioxide
and zinc oxide because of their increased transpar-
ency when applied. The World Health Organization
claims that this will facilitate their acceptance and
application as well as reapplication, by the consumer.
In August 2007, we witnessed the release of
Nanotechnology & Sunscreens: A consumer guide for
avoiding nano-sunscreens by Friends of the Earth.
The intent of the release is obvious. It incorporates a
color-coded alert system, like the USA’s terrorist
alert hierarchical system, to warn consumers against
products that use nanoparticles. The companies
producing them admit doing so and all the products
of companies that chose not to respond to the queries
of the team that published the release constitute a
suspect class.
Let me begin by congratulating Friends of the
Earth (Australia) and the primary author Ian Illum-
inato, a self-proclaimed health and environmental
campaigner with FOE, and those who signed onto
and contributed to the report including George
Kimbrell of the International Center for Technology
Assessment, Georgia Miller of FOE, Jennifer Sass of
the Natural Resources Defense Council, Erich Pica of
FOE, and Rye Senjen of FOE for maintaining
vigilance. What you do is important and this article
should not be interpreted as an attack on the general
integrity of FOE or these individuals per se.
Furthermore, it is serendipitous that a CAG and this
publication were selected for this exercise. Indeed, an
industrial or regulatory source and one of their
statements or publications could have been selected
and may happen in the near future.
One of their observations in the FOE release is
particularly noteworthy. Too many producers of
sunscreens failed to respond to the request for
information. Companies producing consumer prod-
ucts need to make a genuine effort to increase their
transparency. Some of us have noticed that the
business world of nanotechnology is experiencing
survey fatigue at this time. Too many people are
asking for too much information often without
disclosing how the information would be used. Their
motives may be no less nefarious than those individ-
uals writing the reports, nonetheless responding to as
many queries as possible would be prudent.
In addition, too many people are writing reports
who simply should not because they are not qualified
to do so. Leave the reports to those with the freedom
and willingness to work hard enough to find the best
reasons to believe that something is probable true.
That having been said, what follows is a review of
page five of the FOE report. Page five was selected
because it had the most references and the references
are to the scientific literature purportedly relevant to
the claims being made. Every single reference to a
secondary source material made in the report is
examined against the claims made by the authors of
the source material. The studies were read in their
entirety and the claims made by the scientific
researchers are compared to those in the FOE report.
Finally, the lead or designated author for each of the
referenced studies was contacted and asked whether
the claim made in the report was supported by the
study or review referenced. This part of the exercise
was instructive for another set of reasons. Some of the
authors of the research articles vetted below responded
with their opinion regarding whether the claim made
in the report examined below legitimately referenced
their research, especially Donaldson, Maynard, May-
singer, Gunter Oberdo¨rster, Nel, and Tinkle. One was
highly suspicious, and responded that the articles
should simply be read (which, of course, was done),
but this remark does underscore one reason why the
public has such a difficult time vetting scientific
rhetoric. One did not respond though he received and
opened the email requests. And one could not be
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located electronically and was sent a snail mail
inquiry. We decided to go to press rather than wait
any longer for the responses. In general, we want to
note that the science community was ungrudgingly
cooperative and were genuinely apprehensive about
how their findings were used by others.
Examination and vetting
There were 15 claims made on page five and they are
vetted below. It was not my intention to pick apart
each of these claims against parallel claims made by
the authors of the original study as reported in peer-
reviewed professional journals. Rather my goal was
to contextualize the claims and report any inconsis-
tencies between the FOE claims and those made by
the researchers.
As a quick backgrounder, sunscreens are applied to
the stratum corneum (SC) not to living skin. (The SC is
10–20 lm thick). Keratin, the inactive protein in hair
and fingernails, is the main component of SC. We
regularly slough off the SC every two weeks. As such,
the presence of a sunscreen and its particles is short-
lived. Some of the sunscreen may enter the hair follicle
ostium, but sebum flow tends to flush the follicular
sink and the follicular channel is covered with a horny
layer barrier as well. There is some concern that
nanoparticles in sunscreens may reach living skin
through breaks in the skin, like acne and psoriasis (see
below) and through stressed skin presumably
impacted by sun damage (see below). If and once
they reach the living skin, there are claims that these
nanoparticles can cause DNA damage and cell death.
It is important to note that exposure alone is not
sufficient to claim a risk. There must be enough
exposure to produce the hazard; hence we need to pay
close attention to the dosage of the nanoparticles or
some cascading or proliferating event consequence to
minimal dosage.
After an exhaustive review of the literature, the
majority of the research indicates that titanium oxide
nanopigments do not cross the skin barrier, the
stratum corneum (Mavon et al. 2007; Nohynek et al.
2007; Bu¨tz et al. 2005: Gamer et al. 2006; Roberts
2006; Dussert et al. 1997; Lademann et al. 1999;
Pflu¨cker et al. 1999) transfollicular pathways not-
withstanding (Gottbrath and Mu¨ller-Goymann 2003;
Lekki et al. 2007). Some NANODERM research
makes the same claims in the cases of both healthy
and skin compromised by acne and psoriasis (Pinheiro
et al. 2007). Generally, others report the low hazard
potential on particles used in sunscreens (Li et al.
2007; Warheit et al. 2007) even regarding their
alleged phototoxicity (Theogaraj et al. 2007). Addi-
tionally, the aggregates used in sunscreens simply
may not meet the prevailing definition of a nanopar-
ticle (1–100 nm) in one or more dimension. If they
are many times larger, then transferring findings from
studies on truly nanosized particles of titanium and
zinc oxides may be problematic. Finally, we noted
that even when injected into the stratum corneum,
particles tend to aggregate and are not found in other
organs (Umbreit et al. 2007).
Claim 1—‘‘Particles 1,000 nm in size can cross
human skin and gain access to the dermis from where
they can access the blood stream.’’ The source is
Tinkle et al. (2003). The assumption is that once
particles cross the skin and reach the blood stream
some negative implication occurs. Tinkle et al. is
cited to demonstrate nanoparticles can penetrate
stressed skin. In general, we know the skin sections
that were flexed were relatively thin, about 400 lm.
There is also the observation that the nanoparticles
might have become trapped in hair follicles and
appeared to have traveled into the skin when they did
not. There is a corresponding concern regarding the
pressure exerted on the skin, which may have
confounded the results. Finally, there is the observa-
tion that fluorescent markers detach from
nanoparticles and the results followed the markers
that leached into the tissue rather than the particles.
Next, absolutely missing from this claim is any
discussion of the minimum dosage needed to produce
some hazard. Clearly a single particle would be
insufficient to cause much anticipated damage.
Finally, this study is about beryllium which is not
used in sunscreens. As Tinkle (2007) observed. ‘‘My
research showed that 500–1,000 nm particles, in
conjunction with flexing, as at the wrist, can trans-
locate across intact stratum corneum in human skin
explants (skin recovered from organ donors and
attached to a flexing device on a lab bench). We
occasionally saw particles in the dermis. And we did
not say they could access the blood stream from the
dermis. It is, perhaps, a logical extension of our data,
but we did not say it. Also, we did not study particles
that meet the current National Nanotechnology
28 J Nanopart Res (2008) 10:23–37
123
Initiative definition (materials with one dimension
less than 100 nm). Importantly, these were proof of
concept experiments, and we did not show this in
living human beings.’’ One source for the bloodstream
idea has been Montiero-Riviere et al. (2005) who
studied uncoated carbon nanotubes and not nanopig-
ments used in sunscreens. In the discussion of this
article, we read: ‘‘Evidence of dermal irritation (Eedy
1996) coupled with a report of toxicity to keratino-
cytes (Shvedova et al. 2003) suggests that particles
not optimized for intracellular delivery may enter
cells and adversely affect cellular function’’ (382). As
such, we have the findings of these two studies
conflated to establish an exposure route for the carbon
nanotubes under investigation. Both Eedy and Shve-
dova also studied carbon and not nanopigments used
in sunscreens. Eedy (1996) was a case report about a
single case having airborne contact dermatitis. Eedy
linked it to carbon fibre composite dust particles
released from drilling, cutting, and grinding of carbon
fibre components in an aircraft factory at which the
case worked (362). Shvedova et al. (2003) treated
HaCaT cell culture with single walled carbon nano-
tubes (SWCNT) and found that exposure to unrefined
SWCNT resulted in ultrastructural and morphological
changes in cultured human cells (1924).
Claim 2—‘‘Uptake is increased with flexing and
massage.’’ Source is Tinkle again. First, see above
and then consider there is no discussion of massage in
Tinkle et al. (2003) though a hypothetical discussion
of flexing such as what occurs about the wrist area
could be deduced. However, that observation is
moderated by the pressure exerted and that con-
founding variable is not addressed. Tinkle reported:
‘‘We saw a time-dependent increase in the number of
skin samples that were positive for particle penetra-
tion, that is, with increasing amount of time flexing
on the apparatus, starting at 0–15–30–60 min, more
samples were positive for particles beneath the
stratum corneum. We did not demonstrate an increase
in the number of particles/skin sample over time
because the experimental method was not quantita-
tive. PLEASE NOTE (emphasis was Tinkle’s)—we
used FITC-labeled polystyrene spheres and not metal
oxide particles. We did not use, nor make any
conclusions about, uptake and massage, other than to
cite the Tan et al. (1996) article that applied TiO2
topically to the skin. This was used as background
and context only’’ (2007).
Tan et al. (1996) studied human skin excised from
13 patients. Tan reported in results: ‘‘There was no
correlation between the duration of sunscreen appli-
cation and the concentration of titanium in the
samples, and no relationship between the site of
sunscreen application and concentration of titanium
in the samples’’ (186).
Claim 3—‘‘Broken skin is an ineffective barrier and
enables particles up to 7000 nm in size to reach living
tissue.’’ Source is the three Oberdo¨rsters (2005b). First,
this is not a study; it is a review of the literature. The
three Oberdo¨rsters reference Tinkle (see above) when
discussing nanosized particles. The quote which seems
to be the basis of the claim may be: ‘‘dermal
translocation will therefore be minimal or nonexistent
under normal conditions but increases in areas of skin
flexing (Tinkle et al. 2003) and broken skin’’ (835). An
email communication with Prof. Oberdo¨rster verified
this claim to a study about podoconiosis premised on
the hypothesis that soil particles can reach inguinal
lymph nodes in barefoot runners (Corachan et al. 1988;
Blundell et al. 1989). The Corachan et al. work
involves two cases of field workers and in their
discussion they noted ‘‘any barefoot population exert-
ing gravity pressure on different types of soil
containing microparticles can develop podoconiosis’’
(363). The role of pressure in this study is simply not
addressed in Tinkle’s work. The Blundell et al. piece
involved a survey of a single Cameroonian woman
with elephantiasis and was challenged to explain ‘‘why
the majority of the populations who are exposed to a
similar environment fail to develop the disease’’ (385).
In addition, how particles go from lymph nodes to
the circulatory system comes from a 1988 study on
amosite fibers and the lungs (Oberdo¨rster et al. 1988).
This is inhalation research not dermal penetration and
seems to be dependent on an extrapolation from the
Corachan and Blundell research to demonstrate a
route of exposure as well. Whether there may be a
similar translocation from dermal exposure seems
very speculative.
Oberdo¨rsters asked hypothetically:…’’ how likely is
this to occur in the dermis layer of the skin with its dense
supply of different types of sensory nerves? It may be
conceivable considering data on neuronal uptake and
translocation of nanosized particles after intramuscular
injection’’ (835–836). In the very next paragraph, the
Obserdo¨rsters add: ‘‘Future studies need to determine
whether and to what degree such translocation along
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sensory skin neurons also occurs with nanosized
particles penetrating the epidermis’’ (836).
Claim 4—‘‘Many types of nanoparticles interfere
with normal cellular function, and cause oxidative
damage and even cell death.’’ Source is Borm and
Kreyling (2004). First, this is an inhalation study not a
dermal study; hence these implications are wholly
dependent on the earlier transport claims. Further-
more, this study lauds the use of polymeric
nanoparticles as drug delivery systems with significant
reductions in adverse drug reactions; hence risk values
may need to be comparative. Second, this claim is
highly moderated by dosage considerations. The
authors establish that caveat as well (523).Third, they
admit the surfaces of titanium oxides are sometimes
chemically very active (523) and couch this discussion
exclusively to exposure from inhalation (524). Fur-
thermore, they add; ‘‘Conflicting studies (in animals
and humans) have been reported regarding particle
translocation after inhalation…’’ (526).
Claim 5—‘‘Some nanoparticle types may also be
transported within cells and be taken up by cell
mitochondria.’’ Source is Oberdo¨rster et al. (2005a).
This is a review of research and not original work. The
relevant source is Li et al. (2003) and it is an inhalation
study (see below under claim 6). ‘‘The study used
collected ambient nanoparticles (as well as larger
ambient particles), and so may not be directly trans-
latable to engineered nanoparticles, or non-carbon
based nanoparticles (depending on uptake mechanism).
In vitro tests were conducted, using cells either found
in the lung, or that mimicked lung cell behavior. Thus
the results shed possible light on what happens when
incidental nanoparticles are inhaled and deposited in
the lungs (with the emphasis on ‘‘possible’’, as the tests
were conducted outside the body, under idealized
conditions). They also allow us to hypothesize over
what might happen if engineered nanoparticles are
inhaled, and possibly what could happen if nanopar-
ticles reach similar cells in other parts of the body—for
instance, if they penetrated the outer layers of the skin’’
(Maynard 2007). Professor Maynard continued. ‘‘The
use of this study in the context of TiO2/ZnO nanopar-
ticle exposure from topical applications is therefore
rather speculative. The assumption-chain is that:
1. Nanoparticles can penetrate to cells that have
similar characteristics to lung epithelial cells and
macrophages;
2. The carrier/matrix that the nanoparticles are in
does not alter their behavior;
3. The particles used in sunscreens have similar
physicochemical characteristics to ambient nano-
particles—specifically, characteristics that
govern biological transport and uptake; and
4. The data from in vitro tests on ambient nanopar-
ticles related to the lungs can be extended to
in vivo impacts of metal oxide particles on the
skin WITHOUT FURTHER STUDIES (Empha-
sis is Maynard’s).
There is the further implicit assumption that the
presence of the nanoparticles in the mitochondria is
important. But without information on dose, and
response, this is an assumption that cannot be made.’’
Maynard concluded ‘‘The cited study raises
important questions over how nanoparticles might
behave in the body, and supports the formulation of a
number of hypotheses. Yet while the claim made is
technically accurate, how it is used within the context
of the FOE is not justified when the limitations of the
study are compared to the materials and scenarios
being discussed.’’
Claim 6—‘‘Some nanoparticle types cause cell
mutation.’’ Sources are Li et al. (2003) and Savic
et al. (2003). We begin with Li et al. (2003). This is
an inhalation study of organic particulate matter in
the Los Angeles Basin. It remains unclear as to what
characteristics of the ultrafines studied by this team
are responsible for the findings of oxidative stress.
While the ultrafines studied should be attended to in
terms of regulating exposure from inhalation, it is
unclear whether the nanopigments used in sunscreens
would be inhaled at dosage levels sufficient to
produce a similar effect and whether the findings
associated with the organic particulate matter studied
by this team are transferable to the nanopigments
used in sunscreens. Next we have Savic et al. (2003).
The contact person for the article responded directly
to the claim made by FOE. ‘‘Our reference (Savic
et al. 2003) is not adequately cited to support the
claim for two reasons: (1) it does not deal with
metallic nanoparticles (TiO) and (2) there is no claim
in our article that polycaprolactone-b-polyethylene
oxide causes mutations’’ (Maysinger 2007).
Claim 7—‘‘Some nanoparticle types even result in
cell death.’’ Source is Geiser et al. (2005). First, this
is as good a place as any to note that we lose
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50,000,000 cells every second. Unless nanoparticles
can be held responsible for the death of a threshold of
cells, it may not be an issue worth our consideration
given what we know at this time. No one has
suggested that nanoparticles alone would be sufficient
to kill enough or the right combination of cells to
produce an imminent health hazard. The most
condemning research has involved inhalation studies
of rodents to date and conclusions related to respi-
rable titanium oxide have been mixed. Geiser’s study
pertains to high levels of airborne particles (1555)
and the subject of the research is air pollution and not
titanium oxide. Second, workers have and can be
protected. The likelihood a casual application of
sunscreen would release sufficient respirable titanium
oxide to produce a health hazard has never been
supported by evidence.
Claim 8—‘‘Titanium dioxide has been classified as
a possible carcinogen for humans, based on rodent
data.’’ Source is The World Health Organization’s
International Agency for Research in Cancer (IARC)
(2006). In terms of selective reporting, note that the
IARC offers this advice: ‘‘Studies on the application
of sunscreens containing ultrafine titanium dioxide to
healthy skin of human volunteers revealed that
titanium dioxide particles only penetrate into the
outermost layers of the stratum corneum, suggesting
that healthy skin is an effective barrier to titanium
dioxide. There are no studies on penetration of
titanium dioxide in compromised skin’’ (3). This
group was incredibly hesitant to offer the claim of
possible carcinogenicity. Once you discount the
inhalation research, this conclusion cannot be sus-
tained. ‘‘Oral, subcutaneous, and intraperitoneal
administration did not produce a significant increase
in the frequency of any type of tumor in mice or rats’’
(2). Even the conclusion cited above is suspect upon
reading the caveats preceding the claim. ‘‘There is
inadequate evidence in humans for the carcinogenic-
ity of titanium dioxide’’ (5). Finally, workers in the
production of titanium oxides are safer than ever.
‘‘Levels of exposure to respirable dust in these
occupations ranged between \1 and 5 mg/m3 (geo-
metric mean) but have declined over time. No data
were available that would allow the characterization
or quantification of exposure to ultrafine primary
particles’’ (1). Furthermore, isolating titanium oxide
as the cause of disease in workers is incredibly
problematic given: ‘‘Workers in the titanium dioxide
manufacturing industry may also be exposed to ore
and other dusts, strong acids and asbestos’’ (1).
Claim 9—‘‘Nanoparticles are much more likely
than larger particles to form free radicals.’’ Source is
Nel et al. (2006). Nel did offer a brief response: ‘‘It
does not talk about sunscreens or metal oxides but
there are other studies that do show adverse biolog-
ical responses to metal oxides, including
mitochondrial damage.’’ He added, ‘‘You will not
see quote 9 coming out of that source as stated’’ (Nel
2007) and see above.
Claim 10—‘‘Free radicals cause damage to DNA
and can harm our delicate skin in many ways.’’
Sources are Donaldson et al. (1996) and Dunford
et al. (1997). This is a good place to make a
comparative risk assessment.
There is an extensive literature that accords to
sunscreens the capacity to reduce DNA damage
(Gallagher 2005; Lee et al. 2005; Mahroos et al.
2002; Young et al. 2000; Gallagher et al. 2000a;
Gallagher et al. 2000b). Gallagher of the Cancer
Control Research Program of the British Columbia
Cancer Agency (2005) reported that ‘‘a number of
trials have provided good evidence that, when applied
consistently, sunscreens can realistically play a role
in reducing the risk of squamous cell carcinoma’’
(244). Approximately, 1 in 20 develops this type of
carcinoma. Gallagher does admit no effect on basal
cell carcinoma which is three times more frequent.
Lee et al. (2005) studied nevus development among a
randomized sample of 300 white children to deter-
mine whether nevus density may have increased with
increased sunscreen use. Earlier studies did not
control for phenotype and prior sun exposure though
they discovered a positive association between sun-
screen use and new nevi (Autier et al. 1998; Luther
et al. 1996). Lee et al. discovered the sunscreen group
developed fewer new nevi and nevus density is a
predictor of cutaneous malignant melanoma. Mah-
roos et al. (2002) tested 18 women over a 4-day
period, under controlled exposures to UV radiation,
and measured thymine dimer formation. They
reported ‘‘regular use of a broad-spectrum sunscreen
is effective in preventing a major form of UV-
induced DNA damage’’ (1480). Young et al. (2000)
reported: ‘‘Protection by a broad spectrum UVA
sunscreen may offer additional protection from
oxidative damage to DNA caused by UVA’’ (40).
Gallagher et al. (2000a) studied nearly 700 children
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and concluded, ‘‘that broad-spectrum sunscreens may
attenuate the development of nevi in children and
perhaps ultimately reduce their risk of developing
melanoma’’ (html, n. pag.). Gallagher et al. (2000b)
replying to a letter to the editor in a later issue added:
‘‘The true degree of protection afforded by sunsc-
reens against nevi will probably always be
underestimated because of ethical concerns and
practical considerations surrounding sunscreen trials’’
(2870). As such, we need to evaluate this claim
comparatively.
First, there is the reference to Donaldson et al.
(1996). ‘‘The article is aimed at showing the link
between particle-derived oxidative stress and inflam-
mation. It shows that TiO2 can damage naked
bacterial plasmid DNA. This is emphatically not an
assay of genotoxic risk; it is simply using bacterial
DNA as a sensor of free radicals. In mammalian cells
the DNA is closely associated with histone protein
tucked away in the nucleus and surrounded by
antioxidants. In order to measure genotoxic potential
you would have to expose whole cells not naked
bacterial DNA, which is frequently done. There is no
skin in my studies just naked bacterial DNA and,
although it shows DNA damage, it’s not a ‘fair ‘
estimate of the ability of the particles to cause DNA
damage in a whole live cell, since the protective
milieu of the cell and nucleus is absent’’ (Emphasis is
Donaldson’s). Donaldson (2007) continued. ‘‘In the
article I do say ‘...This oxidant burden could cause
classical oxidant damage to lipid, protein and DNA...’
so I said it was possible that DNA damage could be
caused by such particles—but is it emphatically NOT
demonstrated here. I must admit mea culpa in not
making it crystal clear in the article that this is not an
assay of genotoxicity. I had to make this clear quite
often in response to questions after giving talks,
around this time. People get mixed up with the use of
plasmid DNA, and the demonstration of genotoxicity.
In my defence, the whole thrust of the article is
towards inflammation and not genotoxicity, and so I
probably thought it was obvious’’ (Donaldson 2007).
Dunford et al. (1997) is another matter since she
was unreachable as the article went to press. Primar-
ily, there is an exposure issue here. Dunford et al.
admit: ‘‘Our results demonstrate that sunscreen TiO2
and ZnO can catalyze oxidative damage to DNA
in vitro and in cultured human fibroblasts. The fate of
these materials applied to skin is uncertain’’ (89).
Second, we might be more careful when conflating
photocatalytic activity and phototoxic potential.
In addition, Dunford et al. were vetted in a 2006
Australian Review (2006) entitled ‘‘A review of the
scientific literature on the safety of nanoparticulate
titanium dioxide or zinc oxide in sunscreens.’’ First,
there were claims regarding the systems under study
included in vivo though none were actually con-
ducted in vivo. Second, it is unclear whether the
particles studied were nanoparticles. The TiO2 sam-
ples were extracted from marketed sunscreen
products with no reference to size of the particle
extracted. Third, the authors indicate absorption of
TiO2 has yet to be adequately demonstrated (7).
Generally, the exposure issue is tabled in the text by
referencing Dupre et al. (1985), Moran et al. (1991)
and Tan et al. (1996).
Dupre et al. (1985) studied a single patient with a
penile pigmentation allegedly caused by an ointment
called Parkipan containing titanium dioxide. The
patient was treating herpetic lesions and they healed.
The researchers are hesitant to state unequivocally
the titanium oxide in the cream was the cause of the
discoloration. Instead, they hypothesize ‘‘the erosive
lesions may have allowed increased percutaneous
penetration’’ (658). Moran et al. (1991) studied six
patients and studied exposure along different modal-
ities: lung, skin, and synovium. In terms of dermal
exposure, they referenced research demonstrating
allergic reactions in some people when skin lesions
have been treated with topical creams including
TiO2 and as a local irritant when forming part of a
metal alloy implants. But Moran et al. were unable
to isolate the cause of lesions they studied. They
admit that it may be a function of a ‘‘secondary
phenomenon due to contaminants deposited with the
titanium dioxide’’ (352). Tan et al. (1996) is
discussed above.
Claim 11—‘‘Titanium dioxide nanoparticles used
in sunscreen can form free radicals in skin cells.’’
Source is Donaldson et al. (1996). ‘‘I think this is
very obviously an unwarranted extension of what the
paper says. The first half of the sentence is true
‘Titanium- dioxide nanoparticles used in sunscreen
can form free radicals... .’ It is the second part that is
extended by the reviewer of my paper to what he
thinks to be the case—‘in skin cells…’. My paper
does not use skin cells, I have never published an
article that used skin cells and in fact this study does
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not even use cells, only bacterial plasmid DNA. The
kind of TiO2 I used is not used in sunscreen, so there
is also an issue about generalising across different
samples of particles composed of what is nominally
the same material, which can differ a lot, e.g., size
and coating, contaminating metals etc.’’ (Donaldson
2007).
Claim 12—‘‘Titanium dioxide nanoparticles used
in sunscreen can form free radicals in skin cells,
especially when skin is exposed to UV radiation.’’
Source is Dunford et al. (1997). See above and
below.
Claim 13—‘‘The process of skin-damaging free
radical formation is further propelled when we wear
nanoparticle titanium dioxide while in the sun.’’
Source is Dunford et al. (1997) again and see above
again. While the Dunford et al. findings are interesting,
it might behoove us to heed the conclusion of the
Australian Review. ‘‘There is evidence from isolated
experiments than ZnO and TiO2 can induce free radical
formation in the presence of light and that this many
damage these cells. However, this would only be of
concern in people using sunscreens if the ZnO and
TiO2 penetrated into viable skin cells. The weight of
current evidence is that they remain on the surface of
the skin and in the outer dead layer of the skin’’ (15).
Claim 14—‘‘Nanoparticles can also become toxic
vehicles by binding to other foreign materials and
piggy-backing on them into organs and sensitive
areas that cannot normally be accessed.’’ Source is
Lomer et al. (2004). Lomer et al. were studying the
roles of particulates (mainly titanium dioxide) and
particulate silicates in aggravating Crohn’s disease
(CD). CD is an inflammatory bowel disease. There is
neither an argument in this study nor data produced to
support the claim made by this report. This leads us to
assume shoddy end notation.
Claim 15—‘‘Personal care products may also be
inhaled and are often ingested. Some figures show
that over a trillion particles of titanium dioxide are
ingested per person per day.’’ Source is Lomer et al.
(2004) again. We know titanium oxide particulates
are found in toothpaste and some foods and we ingest
1012–1014 particles in our standard Western diets.
First, the study examined food-additive microparti-
cles and not nanoparticles. There is no evidence that
the source is personal care products, such as sunsc-
reens. Production safety protocols tend to
significantly mitigate inhalation risks. Second, there
is no indication that personal care product sources
would significantly increase current exposure. Third,
there was no comparison done comparing those with
Crohn’s disease and those without leading Lomer
et al. to offer this caveat: ‘‘the cause of CD remains
elusive, and whether certain aspects of the diet
exacerbate symptoms is difficult to identify due to the
nature and complexity of dietary habits (954).’’ They
conclude, ‘‘if exposure to microparticles is associated
with the inflammation of CD, then the present study
rules out excess intake as the problem (947).’’ The
study helped identify microparticle containing foods
and was an important first step in assessing dietary
variables in the occurrence of CD but it hardly
evidences the claim made by the report.
Discussion
If everything said above is true, how then can the
August 2007 release be anything more than muck-
raking? Surely it would not pass the scrutiny given to
most academic publications by colleges of faculty.
One of the causes with this confusion lies in the
claim that nanoparticles are different from particles
of a larger size and much of the blame for the
confusion rests with some of the members of the
cosmetics industry itself. Too many companies are
overclaiming the effectiveness of their sunscreens
and cosmetics. In order to differentiate a new
nanoproduct from another non-nanoproduct, adver-
tisers and marketers are stretching the truth and
stoking the concern that motivates some people to
write reports like the one criticized above.
There are at least four classes of nanoparticles
being used in the preparation of sunscreens and
cosmetics. Each class has very different risk profiles.
What some colleagues have done was to conflate all
these classes using the high risks profiles of one class
for all four classes.
The first class involves insoluble nanopigments.
They are minerals, including titanium and zinc oxides
and they are primarily used in sunscreens. They are
inert by design and used as a reference of non-
toxicity as well as used as a coloring agent in food
and dental products as previously mentioned. In
sunscreens, nano-sized titanium oxide may be present
in large clusters or aggregates up to 600 nm.
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The second class includes nanoemulsion products
containing oil and water droplets reduced to nano-
metric size to increase the effectiveness of nutritious
oils. Fragile active ingredients, like vitamins, are
protected from air inside liposomes that release the
ingredient upon contact with the skin at the time of
application. These nanoemulsions are designed to
allow active ingredients to reach beneath the topmost
layer of the skin hence carrying a higher risk profile
than nanopigments.
The third class includes cosmetics that use fuller-
enes or fullersomes as carbon cages for active
ingredients. While carbon nanoparticles, such as
fullerenes, might be hazardous when inhaled and
they may oxidize some cells there is much weaker
evidence that they can be absorbed transdermally. On
the other hand, there are some concerns that a true
life cycle analysis may find them in waste streams
entering the environment though there is some
suggestion they agglomerate easily and would no
longer by nanometric in size. Nonetheless, they
would carry a higher risk profile.
The fourth class includes two subclasses. The first
subclass can be readily dismissed and involves prod-
ucts claiming to dissolve cellulite, to enhance breast
tissues, etc. and there is no evidence they work. There
is also no evidence they function on the nanolevel. The
second subclass involves some claims made by the
pharmaceutical industry and others regarding dermal
application of some compounds which would be
absorbed through the skin into another system, such
as the circulatory or limbic systems. There is interest-
ing research (Kayser and Kiderlen 2003) that confirms
the effectiveness of transdermal drug delivery (TDD)
systems for a limited set of compounds with precise
chemical signatures and to especially invasive devices
such as patches festooned with microtubules which
pierces the SC to deliver their payload. These TDD
systems are quite exploratory at this point in time and
would be regulated under the FDA’s medical device
and drug pre-market review. Nonetheless, their risk
profiles are very high and the cosmetics and sunscreen
industries will be hard pressed to delineate for the
public why their products are not absorbed while the
drugs associated with TDDs are (an issue to be
addressed at a later time).
What has happened is that the risk profiles of the
second, third and especially fourth classes of nano-
products have been transferred to those in the first
class, the nanopigments used in sunscreens. As
mentioned above, it is very difficult to discern
motivations of the proponents of this false claim.
Some has been promulgated by those who benefit
from fear and apprehension including but not limited
to toxicologists and researchers who are intoxicated
by research funding, to some CAGs and individuals
who claim to represent the interests of civil society
but find prestige, stature, membership, and dues
contingent on controversy, and the media who use
timidity and trepidation to sell news and advertise-
ments by amplifying over-claims. Unfortunately, they
have instigated a heightened level of fear in the
general public and that is wrong.
Conclusion
Primarily, this article is not to be read to conclude
there are no transdermal risks from all nanoparticles.
This work is specifically limited to the use of
nanopigments in sunscreens and profiled against a
report by the CAG Friends of the Earth (FOE, 2007).
This article should not be read to conclude that there
are no dermal risks to nanopigments in sunscreens
just that the case made in the FOE publication
referenced throughout may not have been made
satisfactorily. Finally, it is not an apologia for the
cosmetics and sunscreen industry.
If this article draws any conclusion, it may be that
we need to vet reports from stakeholders in the nano-
realm. Whether from the media, CAGs, NGOs,
industry, regulators, or academia, we cannot simply
believe what we are reading. There is no ‘‘Truth in
Advocacy’’ (TIA) team out there that springs to
action when a spurious claim is being made. While
scientists may debunk research findings at profes-
sional meetings and in academic journals, too often
that information does not reach the public. While
stakeholders of all sorts respond that information of
all sorts is available on the World Wide Web, few, if
any, of the sites involved are written for public
consumption. Maybe, we need a ‘‘TIA’’ team or
maybe not, but we do desperately need public
information on the risks associated with nanoparticles
written in a registry that the public can understand.
The discussion associated with this project
included the following set of observations. They are
not rank ordered.
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• Why not attempt to categorize nanoparticles into
classes? This exercise alone would be productive
in increasing understanding for many different
stakeholders. As long as the classifications were
subject to revision as more information became
available, it should not be overly problematic.
Even if the classes were used for provisional
regulations, as long as the regulation had a sunset
provision built into them, they could be re-
examined against a growing body of toxicology
literature
• Scientists need to stop telling the public how
uncertain they are. Instead, develop a calculus
which allows responsiveness in the absence of
certainty. The literature on the precautionary
principle and its variants is only burdensome to
those who have never tried to work their way
through the literature. By and large, ‘‘precaution-
ists’’ are not devolutionists. They are not arguing
we return to some form of tribalism or pre-
industrial society. They are asking for a calculus
for science and technology decision making that
incorporates concerns about the lack of certainty.
This would be a worthy undertaking in expert risk
communication.
• We cannot simply read what we want to believe is
true. A common bias in persuasion theory
involves our tendency to believe what is most in
accordance with our previously held beliefs.
CAGs and every other stakeholder must be on
guard to compensate for this bias in their claims
and reports.
• It behooves all of us to take a very close look at
what we are reading and to refrain from endorsing
material which while being consistent with what
we may want to believe, could be suspect. We
cannot reserve our cynicism for only government
and business generated claims while giving CAGs
and the media a free pass.
• A case can be made for a team of researchers
willing to function to insure the accurateness of
claims made by stakeholders about nanotechnol-
ogy. While this article might be considered as an
example of the work a Truth in Advocacy team
would undertake, it would benefit the stakeholding
community if we had more individuals involved in
the process. In addition, it might be prudent to
establish and maintain a team of this sort under a
more articulated organizational structure to
increase transparency and assure reliability as
well as validity.
Are nanoparticles safe? Nothing is safe, but they may
be safer than chemicals we are currently using for
both the people producing them and those using
them. Without a doubt, more research is required to
identify the conditions under which some specific
types of nanoparticle may be hazardous. As Prof.
Maysinger wrote in one of her emails to me, ‘‘It is
extremely important that (the) public understands that
one can NOT make GENERAL statements for ALL
classes of nanoparticles: some nanoparticles could be
hazardous under CERTAIN conditions.’’ [Emphases
are hers.]
Nanoparticles were included in product lines to
kill neither the workers making the products nor the
consumers buying them. Furthermore, the develop-
ment, production, and incorporation of nanoparticles
into finished products are not inexpensive. My
discussions with colleagues in the business world
lead me to believe that nanoparticles may improve
product lines in many different ways. Nonetheless,
we need to maintain our vigilance.
The phenomenon of risk profile shifting is discon-
certing. Stereotyping the class of nanoparticles and
products using nanoparticles threatens to retard
efforts to use nanoparticles for promising applica-
tions, which despite the associated risk profile could
have significant benefits. Nanoparticles may be used
to bring potable water to those dying of dysentery.
Nanoparticles may be used to bring new more
humane treatments for cancer. And nanoparticles
may even be used to reduce the incidence of skin
cancer. Finally, we must examine the EHS risk profile
of nanoparticles with the most rigorous science and
scientific discipline we can muster and we must craft
our arguments well. The public deserves nothing less
from us.
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